News

›
09
Announcement of regulated information under Law 3556/2007 The company “IATRIKO ATHINON S.A.”, in accordance with Law 3556/2007 (Article 3(i)(bb) and Article 21) and in conjunction with Article 11 of the Hellenic Capital Market Commission’s Decision 1/434/03.07.2007, announces that Mr. Georgios Apostolopoulos, Chairman of the Company (a “person discharging managerial responsibilities” pursuant to Article 13 of Law 3340/2005), purchased 1,825 common registered shares on March 7, 2017, for a total net value of 1,095.00 euros.
09
Announcement of regulated information under Law 3556/2007 The Company “ATHENS MEDICAL CENTER S.A.”, pursuant to Law 3556/2007 (Article 3 (ist), (bb) and Article 21), in conjunction with Article 11 of Decision 1/434/03.07.2007 of the Hellenic Capital Market Commission, announces that Mr. Georgios Apostolopoulos, Chairman of the Company (Person Subject to Notification Obligations under Article 13 of Law 3340/2005), purchased 11,285 ordinary registered shares on 08.03.2017, with a total net value of €7,247.37.
26
Announcement of regulated information under Law 3556/2007 The company “IATRIKO ATHINON S.A.”, in accordance with Law 3556/2007 (Article 3(i)(bb) and Article 21) and in conjunction with Article 11 of the Hellenic Capital Market Commission’s Decision 1/434/03.07.2007, announces that Mr. Georgios Apostolopoulos, Chairman of the Company (a “person discharging managerial responsibilities” pursuant to Article 13 of Law 3340/2005), purchased 126,429 common registered shares on January 25, 2017, for a total net value of 73,960.97 euros.
19
Announcement of regulated information under Law 3556/2007 The company “IATRIKO ATHINON S.A.”, in accordance with Law 3556/2007 (Article 3(i)(bb) and Article 21) and in conjunction with Article 11 of the Hellenic Capital Market Commission’s Decision 1/434/03.07.2007, announces that Mr. Georgios Apostolopoulos, Chairman of the Company (a “person discharging managerial responsibilities” pursuant to Article 13 of Law 3340/2005), purchased 125,000 common registered shares on 17/10/2016, for a total net value of 87,492.50 euros.
30
First Half 2016 Results For yet another year, amidst the economic crisis—and despite the mandatory implementation of the “rebate & clawback” mechanism (an automatic discount/reimbursement system applied to patients’ hospitalization bills) by EOPYY—our Group has managed to maintain its steady, uninterrupted progress. This achievement is a testament to our scientific standing, our investments in state-of-the-art equipment, and the high level of professionalism demonstrated by our staff—including medical, nursing, and administrative personnel—al...